In silico structure-based drug screening of novel antimycobacterial pharmacophores by DOCK-GOLD tandem screening

In silico structure-based drug screening of novel antimycobacterial pharmacophores by DOCK-GOLD tandem screening

Background: Enzymes responsible for cell wall development in Mycobacterium tuberculosis are considered as potential targets of anti-tuberculosis (TB) agents. Mycobacterial cyclopropane mycolic acid synthase 1 (CmaA1) is essential for mycobacterial survival because of its critical role in synthesizin...

Full description

Bibliographic Details
Main Authors: Junichi Taira, Takashi Ito, Hitomi Nakatani, Tomohiro Umei, Hiroki Baba, Shotaro Kawashima, Taira Maruoka, Hideyuki Komatsu, Hiroshi Sakamoto, Shunsuke Aoki
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:International Journal of Mycobacteriology
Subjects:
Cyclopropane mycolic acid synthase 1
DOCK program
GOLD program
Mycobacterium smegmatis
Mycobacterium tuberculosis
structure-based drug screening
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=2;spage=142;epage=148;aulast=Taira

Internet

http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=2;spage=142;epage=148;aulast=Taira

Similar Items